J. Simon

发表

Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling.

Eric Claassen, A. Osterhaus, E. Claassen, 2005, Bulletin of the World Health Organization.

A rodent cell line permissive for entry and reverse transcription of human immunodeficiency virus type 1 has a pre-integration block to productive infection.

W. James, J. Simon, G. A. Schockmel, 1994, The Journal of general virology.

A previously undescribed coronavirus associated with respiratory disease in humans.

Theo M Bestebroer, Ron A M Fouchier, Jan C de Jong, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Human Astrovirus Infection in a Patient with New-Onset Celiac Disease

A. Osterhaus, J. Simon, S. Smits, 2010, Journal of Clinical Microbiology.

Human Picobirnaviruses Identified by Molecular Screening of Diarrhea Samples

A. Osterhaus, J. Simon, S. Smits, 2010, Journal of Clinical Microbiology.

The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells

C. K. Grant, M. Malim, R. Fouchier, 1997, Journal of virology.

Vif and the p55Gag Polyprotein of Human Immunodeficiency Virus Type 1 Are Present in Colocalizing Membrane-Free Cytoplasmic Complexes

M. Malim, R. Fouchier, J. Simon, 1999, Journal of Virology.

Efficacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Influenza Vaccines against Pandemic H1N1 (2009) Influenza Virus Infection in Ferrets

R. Rappuoli, T. Kuiken, A. Osterhaus, 2011, Journal of Virology.

Modification of the Ferret Model for Pneumonia From Seasonal Human Influenza A Virus Infection

T. Kuiken, A. Osterhaus, G. Amerongen, 2012, Veterinary pathology.

Mutational Analysis of the Human Immunodeficiency Virus Type 1 Vif Protein

M. Malim, R. Fouchier, J. Simon, 1999, Journal of Virology.

Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function.

M. Malim, R. Fouchier, J. Simon, 1998, Virology.

The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross‐species transmission

M. Malim, M. Soares, K. Peden, 1998, The EMBO journal.

Efﬁcacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Inﬂuenza Vaccines against Pandemic H1N1 (2009) Inﬂuenza Virus Infection in Ferrets (cid:1)

R. Rappuoli, T. Kuiken, G. Rimmelzwaan, 2011 .

Identification and characterization of deer astroviruses.

T. Kuiken, A. Osterhaus, J. Simon, 2010, The Journal of general virology.

Short Communication Identification and characterization of deer astroviruses

T. Kuiken, A. Osterhaus, J. Simon, 2010 .

Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1

Q. Sattentau, A. Barclay, W. James, 1997, Journal of virology.

Role of CD 4 Epitopes outside the gp 120-Binding Site during Entry of Human Immunodeficiency Virus Type 1

Q. Sattentau, A. Barclay, W. James, 1996 .

A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection

W. James, J. Simon, M. Collin, 1993, The Journal of experimental medicine.

Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine.

A. Osterhaus, G. van Amerongen, H. Poulet, 2010, Vaccine.

The recognition of chimeras of rat and human CD4 by HIV-1 gp120 and by monoclonal antibodies.

W. James, J. Simon, G. A. Schockmel, 1993, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques.

A. Osterhaus, G. van Amerongen, J. Simon, 2008, Antiviral research.

Vaccination of Macaques with Adjuvanted Formalin-Inactivated Influenza A Virus (H5N1) Vaccines: Protection against H5N1 Challenge without Disease Enhancement

A. Osterhaus, Catherine Caillet, J. Simon, 2007, Journal of Virology.

A polyethylene glycol/dextran procedure for the isolation of chromatin proteins (histones and nonhistones) from wheat germ.

J. Simon, W. M. Becker, 1976, Biochimica et biophysica acta.

Heterokaryons formed between a rat myeloma and a mouse fibroblast are permissive for entry of HIV type 1.

W. James, J. Simon, 1994, AIDS research and human retroviruses.

Metagenomic Analysis of the Viral Flora of Pine Marten and European Badger Feces

A. Osterhaus, J. V. D. van den Brand, B. Haagmans, 2011, Journal of Virology.

Genogroup I and II Picobirnaviruses in Respiratory Tracts of Pigs

J. Peiris, L. Poon, A. Osterhaus, 2011, Emerging infectious diseases.

HIV‐1 infection of non‐dividing cells: evidence that the amino‐terminal basic region of the viral matrix protein is important for Gag processing but not for post‐entry nuclear import

M. Malim, B. Meyer, R. Fouchier, 1997, The EMBO journal.

Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes

M. Malim, J. Peterson, B. Meyer, 1995, Journal of virology.

The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes

M. Malim, J. Simon, James H. M. Simon, 1996, Journal of virology.

The receptor for HIV: dissection of CD4 and studies on putative accessory factors.

R. Weiss, W. James, J. Simon, 1996, Current topics in microbiology and immunology.

Interaction of the Human Immunodeficiency Virus Type 1 Vpr Protein with the Nuclear Pore Complex

M. Malim, B. Meyer, R. Fouchier, 1998, Journal of Virology.

Evidence for a newly discovered cellular anti-HIV-1 phenotype

M. Malim, R. Fouchier, J. Simon, 1998, Nature Medicine.

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine

A. Osterhaus, G. van Amerongen, E. Hanon, 2008, PloS one.

Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins

M. Malim, R. Fouchier, J. Simon, 1996, Journal of virology.

Pulmonary pathology of pandemic influenza A/H1N1 virus (2009)-infected ferrets upon longitudinal evaluation by computed tomography

T. Kuiken, A. Osterhaus, G. Krestin, 2011, The Journal of general virology.

Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.

A. Osterhaus, J. V. D. van den Brand, G. van Amerongen, 2011, Vaccine.

Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus

Ron A M Fouchier, Thijs Kuiken, T. Kuiken, 2010, The Journal of infectious diseases.

Seasonal Influenza Vaccine Provides Priming for A/H1N1 Immunization

R. Rappuoli, A. Osterhaus, G. van Amerongen, 2009, Science Translational Medicine.

Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets.

T. Kuiken, A. Osterhaus, G. van Amerongen, 2011, Vaccine.